ALBUPAD

Visit website Suggest an edit

About

Developed a proprietary biomaterial made from albumin — fully biocompatible and biodegradable — engineered for next-generation drug delivery and tissue engineering, with natural tumour tropism and built-in imaging visibility. Founded 2023.

Recent news

Know ALBUPAD?

We list a record's team, investors, portfolio and events once we can verify them. Send us what you know and we'll check it.

Suggest an edit